国际抗癫痫联盟心理工作组循证建议：成人和儿童癫痫患者的心理治疗_Journal of Epilepsy

Authors：

 RosaMichaelis , VenusTang , Laura HGoldstein , 肖英凤　译 , 童馨　慕洁　审

Corresponding author：

RosaMichaelis, Email: rosa.michaelis@uni-wh.de

Keywords：

焦虑; 抑郁; 非药物治疗; 心理教育; 病耻感; 筛选

DOI：

10.7507/2096-0247.20190051

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

社会心理因素和癫痫治疗可能对癫痫患者及其家庭的健康相关生活质量（Health-related quality of life，HRQOL）产生显著影响，临床上广泛关注心理评估和治疗在改善 HRQOL 和癫痫共病中的作用。因此，国际抗癫痫联盟（ILAE）委托心理工作组，基于其最近对癫痫患者心理治疗的 Cochrane 回顾证据的评估，制定了相关临床建议。近期关于癫痫患者心理治疗随机对照试验的 Cochrane 回顾是本文的主要证据来源。为提供具有实用意义的指导，我们根据美国神经病学学会证据水平系统以及推荐分级、评估、开发和评价系统对研究设计进行评级。本文是儿童和成人心理学家、神经病学家、精神病学家和神经精神病学家进行国际合作的顶点。ILAE 执行委员会审查并批准了这一进程和结论。心理干预的最强证据被确定为最常见的心理健康问题，包括抑郁症、神经认知障碍和药物依从性。针对提高 HRQOL 和依从性以及减少共病症状（焦虑、抑郁）的心理干预应纳入癫痫综合护理中。一系列的心理策略（如认知行为疗法和正念疗法）为提升癫痫患者生活质量带来希望，也给癫痫临床工作者提供了治疗癫痫共病、应对挑战的临床建议。

Citation： RosaMichaelis, VenusTang, Laura HGoldstein, 肖英凤　译, 童馨　慕洁　审. 国际抗癫痫联盟心理工作组循证建议：成人和儿童癫痫患者的心理治疗. Journal of Epilepsy, 2019, 5(4): 297-311. doi: 10.7507/2096-0247.20190051 Copy

1.	Wang J, Wang Y, Wang LB, et al. A comparison of quality oflife in adolescents with epilepsy or asthma using the Short-Form Health Survey (SF-36). Epilepsy Res, 2012, 101(1-2): 157-165.
2.	Modi AC, Ingerski LM, Rausch JR, et al. Treatment factors affecting longitudinal quality of life in new onset pediatric epilepsy. J Pediatr Psychol, 2011, 36(4): 466-475.
3.	Loiselle K, Ramsey RR, Rausch JR, et al. Trajectories of healthrelated quality of life among youth with newly diagnosed epilepsy. J Pediatr Psychol, 2016, 41(9): 1011-1021.
4.	Ramsey RR, Loiselle K, Rausch JR, et al. Predictors of trajectories of epilepsy-specific quality of life among children newly diagnosed with epilepsy. Epilepsy Behav, 2016, 57(Pt A): 202-210.
5.	Wu YP, Follansbee-Junger K, Rausch J, et al. Parent and family stress factors predict health-related quality in pediatric patients with new-onset epilepsy. Epilepsia, 2014, 55(6): 866-877.
6.	Ferro MA, Camfield CS, Levin SD, et al. Trajectories of health related quality of life in children with epilepsy: a cohort study. Epilepsia, 2013, 54(11): 1889-1897.
7.	Suurmeijer TP, Reuvenkamp MF, Aldenkamp BP. Social functioning, psychological functioning, and quality of life in epilepsy. Epilepsia, 2001, 42(9): 1160-1168.
8.	Taylor J, Jacoby A, Baker GA, et al. Factors predictive of resilience and vulnerability in new-onset epilepsy. Epilepsia, 2011, 52(3): 610-618.
9.	Ridsdale L, Wojewodka G, Robinson E, et al. Characteristics associated with quality of life among people with drug-resistant epilepsy. J Neurol, 2017, 264(6): 1174-1184.
10.	Tang V, Michaelis R, Kwan P. Psychobehavioral therapy for epilepsy. Epilepsy Behav, 2014, 32: 147-155.
11.	Wagner JL, Modi AC, Johnson EK, et al. Self-management interventions in pediatric epilepsy: what is the level of evidence. Epilepsia, 2017, 58(5): 743-754.
12.	Michaelis R, Tang V, Wagner JL, et al. Psychological treatments for people with epilepsy. Cochrane Database Syst Rev, 2017, 10: CD012081.
13.	Michaelis R, Tang V, Wagner JL, et al. Cochrane systematic review and meta-analysis of the impact of psychological treatments for people with epilepsy on health-related quality of life. Epilepsia, 2018, 59(2): 315-332.
14.	Kerr M, Gil-Nagel A, Glynn M, et al. Treatment of behavioral problems in intellectually disabled adult patients with epilepsy. Epilepsia, 2013, 54(Suppl 1): 34-40.
15.	Barry JJ, Ettinger AB, Friel P, et al. Consensus statement: the evaluation and treatment of people with epilepsy and affective disorders. Epilepsy Behav, 2008, 13(suppl 1): S1-29.
16.	Gross R, Johnston K. Levels of evidence: taking neurology to the next level. Neurology, 2009, 72: 8-10.
17.	Atkins D, Best D, Briss PA, et al. Grading quality of evidence and strength of recommendations. BMJ, 2004, 28(7454): 1490.
18.	Guyatt GH, Oxman AD, Vist GE, et al. An emerging consensus on rating quality of evidence and strength of recommendations. BMJ, 2008, 336(7650): 924-926.
19.	Tolin TF, Forman EM, McKay D. Empirically supported treatment: recommendations for a new model. Clin Psychol Sci Pract, 2015, 22(4): 317-338.
20.	Labiner DM, Bagic AI, Herman ST, et al. Essential services, personnel, and facilities in specialized epilepsy centers-revised 2010 guidelines. Epilepsia, 2010, 51(11): 2322-2333.
21.	Guilfoyle SM, Follansbee-Junger K, Modi A. Development and implementation of psychosocial service into standard medical care for pediatric epilepsy. Clin Pract Pediatr Psychol, 2013, 1: 276-288.
22.	Guilfoyle SM, Monahan S, Wesolowski C, et al. Depression screening in pediatric epilepsy: evidence for the benefit of a behavioral medicine service in early detection. Epilepsy Behav, 2015, 44: 5-10.
23.	Ryan JL, McGrady ME, Guilfoyle SM, et al. Health care charges of youth newly diagnosed with epilepsy. Neurology, 2015, 85(6): 490-497.
24.	Tellez-Zenteno JF, Patten SB, Jette N, et al. Psychiatric comorbidity in epilepsy: a population-based analysis. Epilepsia, 2007, 48(12): 2336-2344.
25.	Selassie AW, Wilson DA, Wagner JL, et al. Population-based comparative analysis of risk of death in children and adolescents with epilepsy and migraine. Epilepsia, 2015, 56(12): 1957-1965.
26.	Kerr MP, Mensah S, Besag F, et al. International consensus clinical practice statements for the treatment of neuropsychiatric conditions associated with epilepsy. Epilepsia, 2011, 52(11): 2133-2138.
27.	Fountain NB, Van Ness PC, Bennett A, et al. Quality improvement in neurology: epilepsy update quality measurement set. Neurology, 2015, 84(14): 1483-1487.
28.	Gilliam FG, Barry JJ, Hermann BP, et al. Rapid detection of major depression in epilepsy: a multicentre study. Lancet Neurol, 2006, 5(5): 399-405.
29.	Friedman DE, Kung DH, Laowattana S, et al. Identifying depression in epilepsy in a busy clinical setting is enhanced with systematic screening. Seizure, 2009, 18(6): 429-433.
30.	Wagner JL, Kellermann T, Mueller M, et al. Development and validation of the NDDI-E-Y: a screening tool for depressive symptoms in pediatric epilepsy. Epilepsia, 2016, 57(8): 1265-1270.
31.	Cramer JA, Perrine K, Devinsky O, et al. Development and cross-cultural translations of a 31-item quality of life in epilepsy inventory. Epilepsia, 1998, 39(1): 81-88.
32.	Cramer JA, Westbrook LE, Devinsky O, et al. Development of the quality of life in epilepsy inventory for adolescents: the QOLIE-AD-48. Epilepsia, 1999, 40(8): 1114-1121.
33.	Follansbee-Junger KW, Mann KA, Guilfoyle SM, et al. Development of the PedsQLTM epilepsy module: focus group and cognitive interviews. Epilepsy Behav, 2016, 62: 115-120.
34.	Modi AC, Junger KF, Mara C, et al. Validation of the PedsQL epilepsy module: a pediatric epilepsy-specific quality of life measure. Epilepsia, 2017, 58(11): 1920-1930.
35.	Ferro MA, Goodwin SW, Sabaz M, et al. Measurement equivalence of the newly developed Quality of Life in Childhood Epilepsy Questionnaire (QOLCE-55). Epilepsia, 2016, 57(3): 427-435.
36.	Sabaz M, Lawson JA, Cairns DR, et al. Validation of the quality of life in childhood epilepsy questionnaire in American epilepsy patients. Epilepsy Behav, 2003, 4(6): 680-691.
37.	Marsh L, Rao V. Psychiatric complications in patients with epilepsy: a review. Epilepsy Res, 2002, 49(1): 11-33.
38.	Kanner AM, Schachter SC, Barry JJ, et al. Depression and epilepsy: epidemiologic and neurobiologic perspectives that may explain their high comorbid occurrence. Epilepsy Behav, 2012, 24(2): 156-168.
39.	Modi AC, Rausch JR, Glauser TA. Patterns of non-adherence to antiepileptic drug therapy in children with newly diagnosed epilepsy. JAMA, 2011, 305(16): 1669-1676.
40.	Morita DA, Glauser TA, Modi AC. Development and validation of the Pediatric Epilepsy Side Effects Questionnaire. Neurology, 2012, 79(12): 1252-1258.
41.	Baker GA, Francis P, Middleton A, et al. Development of apatient-based symptom check list to quantify adverse events in persons receiving antiepileptic drugs. Epilepsia, 1993, 34: 18.
42.	Baker GA, Francis P, Middleton A, et al. Initial development, reliability, and validity of a patient-based adverse drug event scale. Epilepsia, 1994, 35: 80.
43.	Mash EJ, Barkley RA. Assessment of childhood disorders. New York, NY: Guilford Press, 2009.
44.	Eiser C, Varni JW. Health-related quality of life and symptom reporting: similarities and differences between children and their parents. Eur J Pediatr, 2013, 172(10): 1299-1304.
45.	CAROLE Group. Epilepsies and time to diagnosis. Descriptive results of the CAROLE survey. Rev Neurol, 2000, 156(5): 481-490.
46.	Kwong KL, Wong SN, So KT. Parental perception, worries and needs in children with epilepsy. Acta Paediatr, 2000, 89(5): 593-596.
47.	Long L, Reeves AL, Moore JL, et al. An assessment of epilepsy patients’ knowledge of their disorder. Epilepsia, 2000, 41(6): 727-731.
48.	Sare G, Rawnsley M, Stoneman A, et al. Men with epilepsy— the lost tribe? Results of a nationwide survey of men with epilepsy living in the UK. Seizure, 2007, 16(5): 384-396.
49.	Shore C, Austin JK, Musick B, et al. Psychosocial care needs ofparents of children with new-onset seizures. Neurosci Nurs, 1998, 30(3): 169-174.
50.	Fraser RT, Johnson EK, Miller JW, et al. Managing epilepsywell: self-management needs assessment. Epilepsy Behav, 2011, 20(2): 291-298.
51.	Shallcross AJ, Becker DA, Singh A, et al. Illness perceptions mediate the relationship between depression and quality of life in patients with epilepsy. Epilepsia, 2015, 56(11): 186-190.
52.	Rawlings G, Brown I, Reuber M. Predictors of health-related quality of life in patients with epilepsy and psychogenic nonepileptic seizures. Epilepsy Behav, 2017, 68: 153-158.
53.	Dash D, Sebastian TM, Aggarwal M, et al. Impact of health education on drug adherence and self-care in people with epilepsy with low education. Epilepsy Behav, 2015, 44: 213-217.
54.	Beretta S, Beghi E, Messina P, et al. Comprehensive educational plan for patients with epilepsy and comorbidity (EDU-COM): a pragmatic randomised trial. J Neurol Neurosurg Psychiatry, 2014, 85(8): 889-894.
55.	Pfafflin M, Schmitz B, May TW. Efficacy of the epilepsy nurse: results of a randomised controlled study. Epilepsia, 2016, 57(7): 1190-1198.
56.	Helde G, Bovim G, Brathen G, et al. A structured, nurse-led intervention program improves quality of life in patients with epilepsy: a randomised, controlled trial. Epilepsy Behav, 2005, 7(3): 451-457.
57.	Jantzen S, Muller-Godeffroy E, Hallfahrt-Krisl T, et al. FLIP&FLAP—a training programme for children and adolescents with epilepsy, and their parents. Seizure, 2009, 18(7): 478-486.
58.	May TW, Pfafflin M. The efficacy of an educational treatment program for patients with epilepsy (MOSES): results of a controlled, randomised study. Epilepsia, 2002, 43(5): 539-549.
59.	Rau J, May TW, Pf€afflin M, et al. Education of children with epilepsy and their parents by the modular education program epilepsy for families (FAMOSES)—results of an evaluation study [in German]. Rehabilitation (Stuttg), 2006, 45(1): 27-39.
60.	Pfafflin M, Petermann F, Rau J, May TW. The psychoeducational program for children with epilepsy and their parents (FAMOSES): results of a controlled pilot study and a survey of parent satisfaction over a five-year period. Epilepsy Behav, 2012, 25: 11-6.
61.	Lua PL, Neni WS. A randomised controlled trial of an SMSbased mobile epilepsy education system. J Telemed Telecare, 2013, 19(1): 23-28.
62.	Pramuka M, Hendrickson R, Zinski A, et al. A psychosocialself-management program for epilepsy: a randomized pilot study in adults. Epilepsy Behav, 2007, 11(4): 533-545.
63.	Aliasgharpour M, Dehgahn Nayeri N, Yadegary MA, et al. Effects of an educational program on self-management in patients with epilepsy. Seizure, 2013, 22(1): 48-52.
64.	Helgeson DC, Mittan R, Tan SY, et al. Sepulveda epilepsy education: the efficacy of a psychoeducational treatment program in treating medical and psychosocial aspects of epilepsy. Epilepsia, 1990, 31(1): 75-82.
65.	Olley BO, Osinowo HO, Brieger WR. Psycho-educational therapy among Nigerian adult patients with epilepsy: a controlled outcome study. Patient Educ Couns, 2001, 42(1): 25-33.
66.	Ridsdale L, Kwan I, Cryer C, et al. Newly diagnosed epilepsy: can nurse specialists help? A randomized controlled trial. Epilepsia, 2000, 41(8): 1014-1019.
67.	Yadegary MA, Maemodan FG, Nayeri ND, et al. The effect of self-management training on health-related quality of life in patients with epilepsy. Epilepsy Behav, 2015, 50: 108-112.
68.	Quiske A, Helmstaedter C, Lux S, et al. Depression in patients with temporal lobe epilepsy is related to mesial temporal sclerosis. Epilepsy Res, 2000, 39(2): 121-125.
69.	Mula M. Epilepsy: bidirectional link between epilepsy and psychiatric disorder. Nat Rev Neurol, 2012, 8(5): 252-253.
70.	Adelow C, Andersson T, Ahlbom A, et al. Hospitalization forpsychiatric disorders before and after onset of unprovoked seizures/epilepsy. Neurology, 2012, 78(6): 396-401.
71.	Hesdorffer DC, Hauser WA, Olafsson E, et al. Depression andsuicide attempt as risk factors for incident unprovoked seizures. Ann Neurol, 2006, 59(1): 35-41.
72.	Kanner AM, Byrne R, Chicharro A, et al. A lifetime psychiatrichistory predicts a worse seizure outcome following temporal lobectomy. Neurology, 2009, 72(9): 793-799.
73.	Petrovski S, Szoeke CE, Jones NC, et al. Neuropsychiatric symptomatology predicts seizure recurrence in newly treated patients. Neurology, 2010, 75(11): 1015-1021.
74.	Rayner G, Jackson GD, Wilson SJ. Two distinct symptom-based phenotypes of depression in epilepsy yield specific clinical and etiological insights. Epilepsy Behav, 2016, 64.
75.	Chaytor N, Ciechanowski P, Miller JW, et al. Long-term outcomes from the PEARLS randomized trial for the treatment of depression in patients with epilepsy. Epilepsy Behav, 2011, 20(3): 545-549.
76.	Ciechanowski P, Chaytor N, Miller J, et al. PEARLS depression treatment for individuals with epilepsy: a randomised controlled trial. Epilepsy Behav, 2010, 19: 225-231.
77.	Gandy M, Sharpe L, Nicholson Perry K, et al. Cognitive behaviour therapy to improve mood in people with epilepsy: a randomised controlled trial. Cogn Behav Ther, 2014, 43(2): 153-166.
78.	Orjuela-Rojas JM, Martinez-Juarez IE, Ruiz-Chow A, et al. Treatment of depression in patients with temporal lobe epilepsy: a pilot study of cognitive behavioral therapy vs. selective serotonin reuptake inhibitors. Epilepsy Behav, 2015, 51: 176-181.
79.	Schr€oder J, Br€uckner K, Fischer A, et al. Efficacy of a psychological online intervention for depression in people with epilepsy: a randomised controlled trial. Epilepsia, 2014, 55(12): 2069-2076.
80.	Thompson NJ, Walker ER, Obolensky N, et al. Distance delivery of mindfulness-based cognitive therapy for depression: project UPLIFT. Epilepsy Behav, 2010, 19(3): 247-254.
81.	Davis GR, Armstrong HE Jr, Donovan DM, et al. Cognitive behavioral treatment of depressed affect among epileptics: preliminary findings. J Clin Psychol, 1984, 40(4): 930-935.
82.	Li J, Wang X, Meng H, et al. Systemic family therapy of comorbidity of anxiety and depression with epilepsy in adolescents. Psychiatry Investig, 2016, 13: 305-310.
83.	Thompson NJ, Patel AH, Selwa LM, et al. Expanding the efficacy of project UPLIFT: distance delivery of mindfulness-based depression prevention to people with epilepsy. J Consult Clin Psychol, 2015, 83(2): 304-313.
84.	Martinovic Z, Simonovic P, Djokic R. Preventing depression in adolescents with epilepsy. Epilepsy Behav, 2006, 9(4): 619-624.
85.	Caller TA, Ferguson RJ, Roth RM, et al. A cognitive behavioral intervention (HOBSCOTCH) improves quality of life and attention in epilepsy. Epilepsy Behav, 2016, 57(Pt A): 111-117.
86.	Tang V, Poon WS, Kwan P. Mindfulness-based therapy for drug-resistant epilepsy: an assessor-blinded randomised trial. Neurology, 2015, 85(13): 1100-1107.
87.	Tajrishi M, Abbasi S, Najafi Fard T, et al. Efficacy of attribution retraining on mental health of epileptic children. Iran Red Crescent Med J, 2015, 17(10): e19393.
88.	Tan SY, Bruni J. Cognitive-behavior therapy with adult patients withepilepsy: a controlled outcome study. Epilepsia, 1986, 27: 225-233.
89.	Fraser RT, Johnson EK, Lashley S, et al. PACES in epilepsy: results of a self-management randomised controlled trial. Epilepsia, 2015, 56(8): 1264-1274.
90.	Dunn DW, Besag F, Caplan R, et al. Psychiatric and behavioural disorders in children with epilepsy (ILAE Task Force Report): anxiety, depression and childhood epilepsy. Epileptic Disord, 2016, 18: 24-30.
91.	Kellermann T, Mueller M, Carter EG, et al. Prediction of specific depressive symptom clusters in youth with epilepsy: NDDIE-Y vs Neuro-QOL SF. Epilepsia, 2017, 58(8): 1370-1379.
92.	Ekinci O, Titus JB, Rodopman AA, et al. Depression and anxiety in children and adolescents with epilepsy: prevalence, risk factors, and treatment. Epilepsy Behav, 2008, 14(1): 8-18.
93.	Modi AC, Wu YP, Guilfoyle SM, et al. Uninformed clinical decisions resulting from lack of adherence assessment in children with new onset epilepsy. Epilepsy Behav, 2012, 25(4): 481-484.
94.	Modi AC, Pai AL, Hommel KA, et al. Pediatric self-management: a framework for research, practice, and policy. Pediatrics, 2012, 129(2): 473-485.
95.	Gollwitzer S, Kostev K, Hagge M, et al. Nonadherence to antiepileptic drugs in Germany: a retrospective, population-based study. Neurology, 2016, 87: 466-472.
96.	Zeber JE, Copeland LA, Pugh MJ, et al. Variation in antiepileptic drug adherence among older patients with new-onset epilepsy. Ann Pharmacother, 2010, 44: 1896-1904.
97.	Shope JT. Compliance in children and adults: review of studies. Epilepsy Res Suppl, 1988, 1: 23-47.
98.	Modi AC, Wu YP, Rausch JR, et al. Antiepileptic drug nonadherence predicts pediatric epilepsy seizure outcomes. Neurology, 2014, 83(22): 2085-2090.
99.	Lin CY, Chen H, Pakpour AH. Correlation between adherence to antiepileptic drugs and quality of life in patients with epilepsy: a longitudinal study. Epilepsy Behav, 2016, 63: 103-108.
100.	Faught RE, Weiner JR, Guerin A, et al. Impact of nonadherenceto antiepileptic drugs on health care utilization and costs: findings from the RANSOM study. Epilepsia, 2009, 50(3): 501-509.
101.	Thomson KE, Modi AC, Glauser TA, et al. The impact of nonadherence to antiseizure drugs on seizure outcomes in an animal model of epilepsy. Epilepsia, 2017, 58: 1054-1062.
102.	Faught E, Duh MS, Weiner JR, et al. Nonadherence to antiepileptic drugs and increased mortality: findings from the RANSOM Study. Neurology, 2008, 71(20): 1572-1578.
103.	Pakpour AH, Gholami M, Esmaeili R, et al. A randomised controlled multimodal behavioral intervention trial for improving antiepileptic drug adherence. Epilepsy Behav, 2015, 52(Pt A): 133-142.
104.	Modi AC, Guilfoyle SM, Mann KA, et al. A pilot randomized controlled clinical trial to improve antiepileptic drug adherence in young children with epilepsy. Epilepsia, 2016, 57(3): e69-75.
105.	Peterson GM, McLean S, Millingen KS, et al. A randomisedtrial of strategies to improve patient compliance with anticonvulsant therapy. Epilepsia, 1984, 25(4): 412-417.
106.	Dilorio C, Bamps Y, Walker ER, et al. Results of a researchstudy evaluating WebEase, an online epilepsy self-management program. Epilepsy Behav, 2011, 22(3): 469-474.
107.	Dilorio C, Reisinger EL, Yeager KA, et al. A telephone-based self-management program for people with epilepsy. Epilepsy Behav, 2009, 14(1): 232-236.
108.	Modi AC, Mann KA, Urso L, Peugh J. Preliminary feasibility and efficacy of a text and application-based adherence intervention in adolescents with epilepsy. Epilepsy Behav, 2016, 63: 46-49.
109.	Lundgren T, Dahl J, Melin L, et al. Evaluation of acceptanceand commitment therapy for drug refractory epilepsy: a randomised controlled trial in South Africa—a pilot study. Epilepsia, 2006, 47(12): 2173-2179.
110.	Lundgren T, Dahl J, Yardi N, et al. Acceptance and commitment therapy and yoga for drug-refractory epilepsy: a randomised controlled trial. Epilepsy Behav, 2008, 13(1): 102-108.
111.	Reiter JM, Andrews DJ. A neurobehavioral approach for treatment of complex partial epilepsy: efficacy. Seizure, 2000, 9(3): 198-203.
112.	Michaelis R, Schonfeld W, Elsas SM. Trigger self-control andseizure arrest in the Andrews/Reiter behavioral approach to epilepsy: a retrospective analysis of seizure frequency. Epilepsy Behav, 2012, 23(3): 266-271.
113.	Au A, Chan F, Li K, et al. Cognitive-behavioral group treatmentprogram for adults with epilepsy in Hong Kong. Epilepsy Behav, 2003, 4(4): 444-446.
114.	Dahl J, Melin L, Brorson LO, et al. Effects of a broad-spectrum behavior modification treatment program on children with refractory epileptic seizures. Epilepsia, 1985, 26(4): 303-309.
115.	Dahl J, Brorson LO, Melin L. Effects of a broad-spectrum behavioral medicine treatment program on children with refractory epileptic seizures: an 8-year follow-up. Epilepsia, 1992, 33(1): 98-102.
116.	McLaughlin DP, McFarland K. A randomized trial of a group based cognitive behavior therapy program for older adults with epilepsy: the impact on seizure frequency, depression and psychosocial well-being. J Behav Med, 2011, 34(3): 201-207.
117.	Choi-Kwon S, Chung C, Kim H, et al. Factors affecting the quality of life in patients with epilepsy in Seoul, South Korea. Acta Neurol Scand, 2003, 108(6): 428-434.
118.	Newsom-Davis I, Goldstein LH, Fitzpatrick D. Fear of seizures: an investigation and treatment. Seizure, 1998, 7(2): 101-106.
119.	Adewuya AO, Ola BA. Prevalence of and risk factors for anxiety and depressive disorders in Nigerian adolescents with epilepsy. Epilepsy Behav, 2005, 6(3): 342-347.
120.	Jacoby A, Snape D, Baker GA. Epilepsy and social identity: thestigma of a chronic neurological disorder. Lancet Neurol, 2005, 4(3): 171-178.
121.	Williams J, Steel C, Sharp GB, et al. Anxiety in children with epilepsy. Epilepsy Behav, 2003, 4(6): 729-732.
122.	Helmstaedter C, Kurthen M, Lux S, et al. Chronic epilepsy and cognition: a longitudinal study in temporal lobe epilepsy. Ann Neurol, 2003, 54(4): 425-432.
123.	Tang V, Kwan P, Poon WS. Neurocognitive and psychological profiles of adult patients with epilepsy in Hong Kong. Epilepsy Behav, 2013, 29(2): 337-343.
124.	Wilson SJ, Baxendale S, Barr W, et al. Indications and expectations for neuropsychological assessment in routine epilepsy care: report of the ILAE neuropsychology task force, diagnostic methods commission, 2013-2017. Epilepsia, 2015, 56(5): 674-681.
125.	Samarasekera SR, Helmstaedter C, Reuber M. Cognitive impairment in adults with epilepsy: the relationship between subjective and objective assessments of cognition. Epilepsy Behav, 2015, 52(Pt A): 9-13.
126.	Cohen R, Senecky Y, Shuper A, et al. Prevalence of epilepsy and attention-deficit hyperactivity (ADHD) disorder: a population-based study. J Child Neurol, 2013, 28(1): 120-123.
127.	Guilfoyle SM, Wagner JL, Modi AM, et al. Pediatric epilepsy and behavioral health: the state of the literature and directions for evidence-based interprofessional care, training, and research. Clin Pract Pediatr Psychol, 2017, 5: 79-90.
128.	Williams AE, Giust JM, Kronenberger WG, et al. Epilepsy and attention-deficit hyperactivity disorder: links, risks, and challenges. Neuropsychiatr Dis Treat, 2016, 12: 287-296.
129.	Pelham WE Jr, Fabiano GA, Waxmonsky JG, et al. Treatment sequencing for childhood ADHD: a multiple-randomization study of adaptive medication and behavioral interventions. J Clin Child Adolesc Psychol, 2016, 45(4): 396-415.
130.	Kerr EN, Blackwell MC. Near-transfer effects following working memory intervention (Cogmed) in children with symptomatic epilepsy: an open randomized clinical trial. Epilepsia, 2015, 56(11): 1784-192.
131.	Modi AC, Schmidt M, Smith AW, et al. Development of a Web based executive functioning intervention for adolescents with epilepsy: The Epilepsy Journey. Epilepsy Behav, 2017, 72: 114-121.
132.	Baker GA, Brooks J, Buck D. The stigma of epilepsy: a European perspective. Epilepsia, 2000, 41(1): 98-104.
133.	Geerts A, Arts WF, Stroink H, et al. Course and outcome of childhood epilepsy: a 15-year follow-up of the Dutch study of epilepsy in childhood. Epilepsia, 2010, 51: 1189-1197.
134.	Rantanen K, Eriksson K, Nieminen P. Social competence in children with epilepsy—a review. Epilepsy Behav, 2012, 24(3): 295-303.
135.	Rodenburg R, Meijer AM, Dekovic M, Aldenkamp AP. Family factors and psychopathology in children with epilepsy: a literature review. Epilepsy Behav, 2005, 6(4): 488-503.
136.	Goffman E. Stigma: notes on the management of spoiled identity. Englewood Cliffs, NJ: Prentice Hall, 1963.
137.	Santosh D, Kumar TS, Sarma PS, et al. Women with onset of epilepsy prior to marriage: disclose or conceal? Epilepsia, 2007, 48(5): 1007-1010.
138.	Lau KK, Ng PW, Chan CW, et al. Announcement of a new Chinese name for epilepsy. Epilepsia, 2011, 52(2): 420-421.
139.	Hosseini N, Mokhtari S, Momeni E, et al. Effect of motivational interviewing on quality of life in patients with epilepsy. Epilepsy Behav, 2016, 55: 70-74.
140.	McEwan MJ, Espie CA, Metcalfe J, et al. Quality of life and psychosocial development in adolescents with epilepsy: a qualitative investigation using focus group methods. Seizure, 2004, 13(1): 15-31.
141.	Ellis N, Upton D, Thompson P. Epilepsy and the family: a review of current literature. Seizure, 2000, 9(1): 22-30.
142.	Painter E, Rausch JR, Mod AC. Changes in daily activity patterns of caregivers of children with newly diagnosed epilepsy: a case-controlled design. Epilepsy Behav, 2014, 31: 1-6.
143.	Mittan RJ. Psychosocial treatment programs in epilepsy: areview. Epilepsy Behav, 2009, 16(3): 371-380.
144.	Glueckauf RL, Fritz SP, Ecklund-Johnson EP, et al. Video conferencing-based family counseling for rural teenagers with epilepsy: phase 1 findings. Rehabil Psychol, 2002, 47(1): 49-72.
145.	Hufford BJ, Glueckauf RL, Webb PM. Home-based, interactive video conferencing for adolescents with epilepsy and their families. Rehabil Psychol, 1999, 44(2): 176-193.
146.	Bernard RM, Abrami PC, Lou YP, et al. How does distance education compare with classroom instruction? A meta-analysis of the empirical literature. Rev Educ Res, 2004, 74(3): 379-439.
147.	Lenhart A. Teen, social media and technology overview. Washington, DC: Pew Research Center, 2015.
148.	Epilepsy Foundation. UPLIFT [cited 2017 Aug 6]. Availablefrom http://www.epilepsy.com/get-help/managing-your-epilepsy/self-management-programs/uplift.
149.	MOSES [cited 2017 Aug 6]. Available from http://www.mosesschulung.de/moses/die-moses-trainer-trainerinnen/.
150.	famoses [cited 2017 Aug 6]. Available from http://www.famoses.de/fileadmin/_migrated/content_uploads/FAMOSES-Flyer-Trainer-2011_09.pdf.

1. Wang J, Wang Y, Wang LB, et al. A comparison of quality oflife in adolescents with epilepsy or asthma using the Short-Form Health Survey (SF-36). Epilepsy Res, 2012, 101(1-2): 157-165.
2. Modi AC, Ingerski LM, Rausch JR, et al. Treatment factors affecting longitudinal quality of life in new onset pediatric epilepsy. J Pediatr Psychol, 2011, 36(4): 466-475.
3. Loiselle K, Ramsey RR, Rausch JR, et al. Trajectories of healthrelated quality of life among youth with newly diagnosed epilepsy. J Pediatr Psychol, 2016, 41(9): 1011-1021.
4. Ramsey RR, Loiselle K, Rausch JR, et al. Predictors of trajectories of epilepsy-specific quality of life among children newly diagnosed with epilepsy. Epilepsy Behav, 2016, 57(Pt A): 202-210.
5. Wu YP, Follansbee-Junger K, Rausch J, et al. Parent and family stress factors predict health-related quality in pediatric patients with new-onset epilepsy. Epilepsia, 2014, 55(6): 866-877.
6. Ferro MA, Camfield CS, Levin SD, et al. Trajectories of health related quality of life in children with epilepsy: a cohort study. Epilepsia, 2013, 54(11): 1889-1897.
7. Suurmeijer TP, Reuvenkamp MF, Aldenkamp BP. Social functioning, psychological functioning, and quality of life in epilepsy. Epilepsia, 2001, 42(9): 1160-1168.
8. Taylor J, Jacoby A, Baker GA, et al. Factors predictive of resilience and vulnerability in new-onset epilepsy. Epilepsia, 2011, 52(3): 610-618.
9. Ridsdale L, Wojewodka G, Robinson E, et al. Characteristics associated with quality of life among people with drug-resistant epilepsy. J Neurol, 2017, 264(6): 1174-1184.
10. Tang V, Michaelis R, Kwan P. Psychobehavioral therapy for epilepsy. Epilepsy Behav, 2014, 32: 147-155.
11. Wagner JL, Modi AC, Johnson EK, et al. Self-management interventions in pediatric epilepsy: what is the level of evidence. Epilepsia, 2017, 58(5): 743-754.
12. Michaelis R, Tang V, Wagner JL, et al. Psychological treatments for people with epilepsy. Cochrane Database Syst Rev, 2017, 10: CD012081.
13. Michaelis R, Tang V, Wagner JL, et al. Cochrane systematic review and meta-analysis of the impact of psychological treatments for people with epilepsy on health-related quality of life. Epilepsia, 2018, 59(2): 315-332.
14. Kerr M, Gil-Nagel A, Glynn M, et al. Treatment of behavioral problems in intellectually disabled adult patients with epilepsy. Epilepsia, 2013, 54(Suppl 1): 34-40.
15. Barry JJ, Ettinger AB, Friel P, et al. Consensus statement: the evaluation and treatment of people with epilepsy and affective disorders. Epilepsy Behav, 2008, 13(suppl 1): S1-29.
16. Gross R, Johnston K. Levels of evidence: taking neurology to the next level. Neurology, 2009, 72: 8-10.
17. Atkins D, Best D, Briss PA, et al. Grading quality of evidence and strength of recommendations. BMJ, 2004, 28(7454): 1490.
18. Guyatt GH, Oxman AD, Vist GE, et al. An emerging consensus on rating quality of evidence and strength of recommendations. BMJ, 2008, 336(7650): 924-926.
19. Tolin TF, Forman EM, McKay D. Empirically supported treatment: recommendations for a new model. Clin Psychol Sci Pract, 2015, 22(4): 317-338.
20. Labiner DM, Bagic AI, Herman ST, et al. Essential services, personnel, and facilities in specialized epilepsy centers-revised 2010 guidelines. Epilepsia, 2010, 51(11): 2322-2333.
21. Guilfoyle SM, Follansbee-Junger K, Modi A. Development and implementation of psychosocial service into standard medical care for pediatric epilepsy. Clin Pract Pediatr Psychol, 2013, 1: 276-288.
22. Guilfoyle SM, Monahan S, Wesolowski C, et al. Depression screening in pediatric epilepsy: evidence for the benefit of a behavioral medicine service in early detection. Epilepsy Behav, 2015, 44: 5-10.
23. Ryan JL, McGrady ME, Guilfoyle SM, et al. Health care charges of youth newly diagnosed with epilepsy. Neurology, 2015, 85(6): 490-497.
24. Tellez-Zenteno JF, Patten SB, Jette N, et al. Psychiatric comorbidity in epilepsy: a population-based analysis. Epilepsia, 2007, 48(12): 2336-2344.
25. Selassie AW, Wilson DA, Wagner JL, et al. Population-based comparative analysis of risk of death in children and adolescents with epilepsy and migraine. Epilepsia, 2015, 56(12): 1957-1965.
26. Kerr MP, Mensah S, Besag F, et al. International consensus clinical practice statements for the treatment of neuropsychiatric conditions associated with epilepsy. Epilepsia, 2011, 52(11): 2133-2138.
27. Fountain NB, Van Ness PC, Bennett A, et al. Quality improvement in neurology: epilepsy update quality measurement set. Neurology, 2015, 84(14): 1483-1487.
28. Gilliam FG, Barry JJ, Hermann BP, et al. Rapid detection of major depression in epilepsy: a multicentre study. Lancet Neurol, 2006, 5(5): 399-405.
29. Friedman DE, Kung DH, Laowattana S, et al. Identifying depression in epilepsy in a busy clinical setting is enhanced with systematic screening. Seizure, 2009, 18(6): 429-433.
30. Wagner JL, Kellermann T, Mueller M, et al. Development and validation of the NDDI-E-Y: a screening tool for depressive symptoms in pediatric epilepsy. Epilepsia, 2016, 57(8): 1265-1270.
31. Cramer JA, Perrine K, Devinsky O, et al. Development and cross-cultural translations of a 31-item quality of life in epilepsy inventory. Epilepsia, 1998, 39(1): 81-88.
32. Cramer JA, Westbrook LE, Devinsky O, et al. Development of the quality of life in epilepsy inventory for adolescents: the QOLIE-AD-48. Epilepsia, 1999, 40(8): 1114-1121.
33. Follansbee-Junger KW, Mann KA, Guilfoyle SM, et al. Development of the PedsQLTM epilepsy module: focus group and cognitive interviews. Epilepsy Behav, 2016, 62: 115-120.
34. Modi AC, Junger KF, Mara C, et al. Validation of the PedsQL epilepsy module: a pediatric epilepsy-specific quality of life measure. Epilepsia, 2017, 58(11): 1920-1930.
35. Ferro MA, Goodwin SW, Sabaz M, et al. Measurement equivalence of the newly developed Quality of Life in Childhood Epilepsy Questionnaire (QOLCE-55). Epilepsia, 2016, 57(3): 427-435.
36. Sabaz M, Lawson JA, Cairns DR, et al. Validation of the quality of life in childhood epilepsy questionnaire in American epilepsy patients. Epilepsy Behav, 2003, 4(6): 680-691.
37. Marsh L, Rao V. Psychiatric complications in patients with epilepsy: a review. Epilepsy Res, 2002, 49(1): 11-33.
38. Kanner AM, Schachter SC, Barry JJ, et al. Depression and epilepsy: epidemiologic and neurobiologic perspectives that may explain their high comorbid occurrence. Epilepsy Behav, 2012, 24(2): 156-168.
39. Modi AC, Rausch JR, Glauser TA. Patterns of non-adherence to antiepileptic drug therapy in children with newly diagnosed epilepsy. JAMA, 2011, 305(16): 1669-1676.
40. Morita DA, Glauser TA, Modi AC. Development and validation of the Pediatric Epilepsy Side Effects Questionnaire. Neurology, 2012, 79(12): 1252-1258.
41. Baker GA, Francis P, Middleton A, et al. Development of apatient-based symptom check list to quantify adverse events in persons receiving antiepileptic drugs. Epilepsia, 1993, 34: 18.
42. Baker GA, Francis P, Middleton A, et al. Initial development, reliability, and validity of a patient-based adverse drug event scale. Epilepsia, 1994, 35: 80.
43. Mash EJ, Barkley RA. Assessment of childhood disorders. New York, NY: Guilford Press, 2009.
44. Eiser C, Varni JW. Health-related quality of life and symptom reporting: similarities and differences between children and their parents. Eur J Pediatr, 2013, 172(10): 1299-1304.
45. CAROLE Group. Epilepsies and time to diagnosis. Descriptive results of the CAROLE survey. Rev Neurol, 2000, 156(5): 481-490.
46. Kwong KL, Wong SN, So KT. Parental perception, worries and needs in children with epilepsy. Acta Paediatr, 2000, 89(5): 593-596.
47. Long L, Reeves AL, Moore JL, et al. An assessment of epilepsy patients’ knowledge of their disorder. Epilepsia, 2000, 41(6): 727-731.
48. Sare G, Rawnsley M, Stoneman A, et al. Men with epilepsy— the lost tribe? Results of a nationwide survey of men with epilepsy living in the UK. Seizure, 2007, 16(5): 384-396.
49. Shore C, Austin JK, Musick B, et al. Psychosocial care needs ofparents of children with new-onset seizures. Neurosci Nurs, 1998, 30(3): 169-174.
50. Fraser RT, Johnson EK, Miller JW, et al. Managing epilepsywell: self-management needs assessment. Epilepsy Behav, 2011, 20(2): 291-298.
51. Shallcross AJ, Becker DA, Singh A, et al. Illness perceptions mediate the relationship between depression and quality of life in patients with epilepsy. Epilepsia, 2015, 56(11): 186-190.
52. Rawlings G, Brown I, Reuber M. Predictors of health-related quality of life in patients with epilepsy and psychogenic nonepileptic seizures. Epilepsy Behav, 2017, 68: 153-158.
53. Dash D, Sebastian TM, Aggarwal M, et al. Impact of health education on drug adherence and self-care in people with epilepsy with low education. Epilepsy Behav, 2015, 44: 213-217.
54. Beretta S, Beghi E, Messina P, et al. Comprehensive educational plan for patients with epilepsy and comorbidity (EDU-COM): a pragmatic randomised trial. J Neurol Neurosurg Psychiatry, 2014, 85(8): 889-894.
55. Pfafflin M, Schmitz B, May TW. Efficacy of the epilepsy nurse: results of a randomised controlled study. Epilepsia, 2016, 57(7): 1190-1198.
56. Helde G, Bovim G, Brathen G, et al. A structured, nurse-led intervention program improves quality of life in patients with epilepsy: a randomised, controlled trial. Epilepsy Behav, 2005, 7(3): 451-457.
57. Jantzen S, Muller-Godeffroy E, Hallfahrt-Krisl T, et al. FLIP&FLAP—a training programme for children and adolescents with epilepsy, and their parents. Seizure, 2009, 18(7): 478-486.
58. May TW, Pfafflin M. The efficacy of an educational treatment program for patients with epilepsy (MOSES): results of a controlled, randomised study. Epilepsia, 2002, 43(5): 539-549.
59. Rau J, May TW, Pf€afflin M, et al. Education of children with epilepsy and their parents by the modular education program epilepsy for families (FAMOSES)—results of an evaluation study [in German]. Rehabilitation (Stuttg), 2006, 45(1): 27-39.
60. Pfafflin M, Petermann F, Rau J, May TW. The psychoeducational program for children with epilepsy and their parents (FAMOSES): results of a controlled pilot study and a survey of parent satisfaction over a five-year period. Epilepsy Behav, 2012, 25: 11-6.
61. Lua PL, Neni WS. A randomised controlled trial of an SMSbased mobile epilepsy education system. J Telemed Telecare, 2013, 19(1): 23-28.
62. Pramuka M, Hendrickson R, Zinski A, et al. A psychosocialself-management program for epilepsy: a randomized pilot study in adults. Epilepsy Behav, 2007, 11(4): 533-545.
63. Aliasgharpour M, Dehgahn Nayeri N, Yadegary MA, et al. Effects of an educational program on self-management in patients with epilepsy. Seizure, 2013, 22(1): 48-52.
64. Helgeson DC, Mittan R, Tan SY, et al. Sepulveda epilepsy education: the efficacy of a psychoeducational treatment program in treating medical and psychosocial aspects of epilepsy. Epilepsia, 1990, 31(1): 75-82.
65. Olley BO, Osinowo HO, Brieger WR. Psycho-educational therapy among Nigerian adult patients with epilepsy: a controlled outcome study. Patient Educ Couns, 2001, 42(1): 25-33.
66. Ridsdale L, Kwan I, Cryer C, et al. Newly diagnosed epilepsy: can nurse specialists help? A randomized controlled trial. Epilepsia, 2000, 41(8): 1014-1019.
67. Yadegary MA, Maemodan FG, Nayeri ND, et al. The effect of self-management training on health-related quality of life in patients with epilepsy. Epilepsy Behav, 2015, 50: 108-112.
68. Quiske A, Helmstaedter C, Lux S, et al. Depression in patients with temporal lobe epilepsy is related to mesial temporal sclerosis. Epilepsy Res, 2000, 39(2): 121-125.
69. Mula M. Epilepsy: bidirectional link between epilepsy and psychiatric disorder. Nat Rev Neurol, 2012, 8(5): 252-253.
70. Adelow C, Andersson T, Ahlbom A, et al. Hospitalization forpsychiatric disorders before and after onset of unprovoked seizures/epilepsy. Neurology, 2012, 78(6): 396-401.
71. Hesdorffer DC, Hauser WA, Olafsson E, et al. Depression andsuicide attempt as risk factors for incident unprovoked seizures. Ann Neurol, 2006, 59(1): 35-41.
72. Kanner AM, Byrne R, Chicharro A, et al. A lifetime psychiatrichistory predicts a worse seizure outcome following temporal lobectomy. Neurology, 2009, 72(9): 793-799.
73. Petrovski S, Szoeke CE, Jones NC, et al. Neuropsychiatric symptomatology predicts seizure recurrence in newly treated patients. Neurology, 2010, 75(11): 1015-1021.
74. Rayner G, Jackson GD, Wilson SJ. Two distinct symptom-based phenotypes of depression in epilepsy yield specific clinical and etiological insights. Epilepsy Behav, 2016, 64.
75. Chaytor N, Ciechanowski P, Miller JW, et al. Long-term outcomes from the PEARLS randomized trial for the treatment of depression in patients with epilepsy. Epilepsy Behav, 2011, 20(3): 545-549.
76. Ciechanowski P, Chaytor N, Miller J, et al. PEARLS depression treatment for individuals with epilepsy: a randomised controlled trial. Epilepsy Behav, 2010, 19: 225-231.
77. Gandy M, Sharpe L, Nicholson Perry K, et al. Cognitive behaviour therapy to improve mood in people with epilepsy: a randomised controlled trial. Cogn Behav Ther, 2014, 43(2): 153-166.
78. Orjuela-Rojas JM, Martinez-Juarez IE, Ruiz-Chow A, et al. Treatment of depression in patients with temporal lobe epilepsy: a pilot study of cognitive behavioral therapy vs. selective serotonin reuptake inhibitors. Epilepsy Behav, 2015, 51: 176-181.
79. Schr€oder J, Br€uckner K, Fischer A, et al. Efficacy of a psychological online intervention for depression in people with epilepsy: a randomised controlled trial. Epilepsia, 2014, 55(12): 2069-2076.
80. Thompson NJ, Walker ER, Obolensky N, et al. Distance delivery of mindfulness-based cognitive therapy for depression: project UPLIFT. Epilepsy Behav, 2010, 19(3): 247-254.
81. Davis GR, Armstrong HE Jr, Donovan DM, et al. Cognitive behavioral treatment of depressed affect among epileptics: preliminary findings. J Clin Psychol, 1984, 40(4): 930-935.
82. Li J, Wang X, Meng H, et al. Systemic family therapy of comorbidity of anxiety and depression with epilepsy in adolescents. Psychiatry Investig, 2016, 13: 305-310.
83. Thompson NJ, Patel AH, Selwa LM, et al. Expanding the efficacy of project UPLIFT: distance delivery of mindfulness-based depression prevention to people with epilepsy. J Consult Clin Psychol, 2015, 83(2): 304-313.
84. Martinovic Z, Simonovic P, Djokic R. Preventing depression in adolescents with epilepsy. Epilepsy Behav, 2006, 9(4): 619-624.
85. Caller TA, Ferguson RJ, Roth RM, et al. A cognitive behavioral intervention (HOBSCOTCH) improves quality of life and attention in epilepsy. Epilepsy Behav, 2016, 57(Pt A): 111-117.
86. Tang V, Poon WS, Kwan P. Mindfulness-based therapy for drug-resistant epilepsy: an assessor-blinded randomised trial. Neurology, 2015, 85(13): 1100-1107.
87. Tajrishi M, Abbasi S, Najafi Fard T, et al. Efficacy of attribution retraining on mental health of epileptic children. Iran Red Crescent Med J, 2015, 17(10): e19393.
88. Tan SY, Bruni J. Cognitive-behavior therapy with adult patients withepilepsy: a controlled outcome study. Epilepsia, 1986, 27: 225-233.
89. Fraser RT, Johnson EK, Lashley S, et al. PACES in epilepsy: results of a self-management randomised controlled trial. Epilepsia, 2015, 56(8): 1264-1274.
90. Dunn DW, Besag F, Caplan R, et al. Psychiatric and behavioural disorders in children with epilepsy (ILAE Task Force Report): anxiety, depression and childhood epilepsy. Epileptic Disord, 2016, 18: 24-30.
91. Kellermann T, Mueller M, Carter EG, et al. Prediction of specific depressive symptom clusters in youth with epilepsy: NDDIE-Y vs Neuro-QOL SF. Epilepsia, 2017, 58(8): 1370-1379.
92. Ekinci O, Titus JB, Rodopman AA, et al. Depression and anxiety in children and adolescents with epilepsy: prevalence, risk factors, and treatment. Epilepsy Behav, 2008, 14(1): 8-18.
93. Modi AC, Wu YP, Guilfoyle SM, et al. Uninformed clinical decisions resulting from lack of adherence assessment in children with new onset epilepsy. Epilepsy Behav, 2012, 25(4): 481-484.
94. Modi AC, Pai AL, Hommel KA, et al. Pediatric self-management: a framework for research, practice, and policy. Pediatrics, 2012, 129(2): 473-485.
95. Gollwitzer S, Kostev K, Hagge M, et al. Nonadherence to antiepileptic drugs in Germany: a retrospective, population-based study. Neurology, 2016, 87: 466-472.
96. Zeber JE, Copeland LA, Pugh MJ, et al. Variation in antiepileptic drug adherence among older patients with new-onset epilepsy. Ann Pharmacother, 2010, 44: 1896-1904.
97. Shope JT. Compliance in children and adults: review of studies. Epilepsy Res Suppl, 1988, 1: 23-47.
98. Modi AC, Wu YP, Rausch JR, et al. Antiepileptic drug nonadherence predicts pediatric epilepsy seizure outcomes. Neurology, 2014, 83(22): 2085-2090.
99. Lin CY, Chen H, Pakpour AH. Correlation between adherence to antiepileptic drugs and quality of life in patients with epilepsy: a longitudinal study. Epilepsy Behav, 2016, 63: 103-108.
100. Faught RE, Weiner JR, Guerin A, et al. Impact of nonadherenceto antiepileptic drugs on health care utilization and costs: findings from the RANSOM study. Epilepsia, 2009, 50(3): 501-509.
101. Thomson KE, Modi AC, Glauser TA, et al. The impact of nonadherence to antiseizure drugs on seizure outcomes in an animal model of epilepsy. Epilepsia, 2017, 58: 1054-1062.
102. Faught E, Duh MS, Weiner JR, et al. Nonadherence to antiepileptic drugs and increased mortality: findings from the RANSOM Study. Neurology, 2008, 71(20): 1572-1578.
103. Pakpour AH, Gholami M, Esmaeili R, et al. A randomised controlled multimodal behavioral intervention trial for improving antiepileptic drug adherence. Epilepsy Behav, 2015, 52(Pt A): 133-142.
104. Modi AC, Guilfoyle SM, Mann KA, et al. A pilot randomized controlled clinical trial to improve antiepileptic drug adherence in young children with epilepsy. Epilepsia, 2016, 57(3): e69-75.
105. Peterson GM, McLean S, Millingen KS, et al. A randomisedtrial of strategies to improve patient compliance with anticonvulsant therapy. Epilepsia, 1984, 25(4): 412-417.
106. Dilorio C, Bamps Y, Walker ER, et al. Results of a researchstudy evaluating WebEase, an online epilepsy self-management program. Epilepsy Behav, 2011, 22(3): 469-474.
107. Dilorio C, Reisinger EL, Yeager KA, et al. A telephone-based self-management program for people with epilepsy. Epilepsy Behav, 2009, 14(1): 232-236.
108. Modi AC, Mann KA, Urso L, Peugh J. Preliminary feasibility and efficacy of a text and application-based adherence intervention in adolescents with epilepsy. Epilepsy Behav, 2016, 63: 46-49.
109. Lundgren T, Dahl J, Melin L, et al. Evaluation of acceptanceand commitment therapy for drug refractory epilepsy: a randomised controlled trial in South Africa—a pilot study. Epilepsia, 2006, 47(12): 2173-2179.
110. Lundgren T, Dahl J, Yardi N, et al. Acceptance and commitment therapy and yoga for drug-refractory epilepsy: a randomised controlled trial. Epilepsy Behav, 2008, 13(1): 102-108.
111. Reiter JM, Andrews DJ. A neurobehavioral approach for treatment of complex partial epilepsy: efficacy. Seizure, 2000, 9(3): 198-203.
112. Michaelis R, Schonfeld W, Elsas SM. Trigger self-control andseizure arrest in the Andrews/Reiter behavioral approach to epilepsy: a retrospective analysis of seizure frequency. Epilepsy Behav, 2012, 23(3): 266-271.
113. Au A, Chan F, Li K, et al. Cognitive-behavioral group treatmentprogram for adults with epilepsy in Hong Kong. Epilepsy Behav, 2003, 4(4): 444-446.
114. Dahl J, Melin L, Brorson LO, et al. Effects of a broad-spectrum behavior modification treatment program on children with refractory epileptic seizures. Epilepsia, 1985, 26(4): 303-309.
115. Dahl J, Brorson LO, Melin L. Effects of a broad-spectrum behavioral medicine treatment program on children with refractory epileptic seizures: an 8-year follow-up. Epilepsia, 1992, 33(1): 98-102.
116. McLaughlin DP, McFarland K. A randomized trial of a group based cognitive behavior therapy program for older adults with epilepsy: the impact on seizure frequency, depression and psychosocial well-being. J Behav Med, 2011, 34(3): 201-207.
117. Choi-Kwon S, Chung C, Kim H, et al. Factors affecting the quality of life in patients with epilepsy in Seoul, South Korea. Acta Neurol Scand, 2003, 108(6): 428-434.
118. Newsom-Davis I, Goldstein LH, Fitzpatrick D. Fear of seizures: an investigation and treatment. Seizure, 1998, 7(2): 101-106.
119. Adewuya AO, Ola BA. Prevalence of and risk factors for anxiety and depressive disorders in Nigerian adolescents with epilepsy. Epilepsy Behav, 2005, 6(3): 342-347.
120. Jacoby A, Snape D, Baker GA. Epilepsy and social identity: thestigma of a chronic neurological disorder. Lancet Neurol, 2005, 4(3): 171-178.
121. Williams J, Steel C, Sharp GB, et al. Anxiety in children with epilepsy. Epilepsy Behav, 2003, 4(6): 729-732.
122. Helmstaedter C, Kurthen M, Lux S, et al. Chronic epilepsy and cognition: a longitudinal study in temporal lobe epilepsy. Ann Neurol, 2003, 54(4): 425-432.
123. Tang V, Kwan P, Poon WS. Neurocognitive and psychological profiles of adult patients with epilepsy in Hong Kong. Epilepsy Behav, 2013, 29(2): 337-343.
124. Wilson SJ, Baxendale S, Barr W, et al. Indications and expectations for neuropsychological assessment in routine epilepsy care: report of the ILAE neuropsychology task force, diagnostic methods commission, 2013-2017. Epilepsia, 2015, 56(5): 674-681.
125. Samarasekera SR, Helmstaedter C, Reuber M. Cognitive impairment in adults with epilepsy: the relationship between subjective and objective assessments of cognition. Epilepsy Behav, 2015, 52(Pt A): 9-13.
126. Cohen R, Senecky Y, Shuper A, et al. Prevalence of epilepsy and attention-deficit hyperactivity (ADHD) disorder: a population-based study. J Child Neurol, 2013, 28(1): 120-123.
127. Guilfoyle SM, Wagner JL, Modi AM, et al. Pediatric epilepsy and behavioral health: the state of the literature and directions for evidence-based interprofessional care, training, and research. Clin Pract Pediatr Psychol, 2017, 5: 79-90.
128. Williams AE, Giust JM, Kronenberger WG, et al. Epilepsy and attention-deficit hyperactivity disorder: links, risks, and challenges. Neuropsychiatr Dis Treat, 2016, 12: 287-296.
129. Pelham WE Jr, Fabiano GA, Waxmonsky JG, et al. Treatment sequencing for childhood ADHD: a multiple-randomization study of adaptive medication and behavioral interventions. J Clin Child Adolesc Psychol, 2016, 45(4): 396-415.
130. Kerr EN, Blackwell MC. Near-transfer effects following working memory intervention (Cogmed) in children with symptomatic epilepsy: an open randomized clinical trial. Epilepsia, 2015, 56(11): 1784-192.
131. Modi AC, Schmidt M, Smith AW, et al. Development of a Web based executive functioning intervention for adolescents with epilepsy: The Epilepsy Journey. Epilepsy Behav, 2017, 72: 114-121.
132. Baker GA, Brooks J, Buck D. The stigma of epilepsy: a European perspective. Epilepsia, 2000, 41(1): 98-104.
133. Geerts A, Arts WF, Stroink H, et al. Course and outcome of childhood epilepsy: a 15-year follow-up of the Dutch study of epilepsy in childhood. Epilepsia, 2010, 51: 1189-1197.
134. Rantanen K, Eriksson K, Nieminen P. Social competence in children with epilepsy—a review. Epilepsy Behav, 2012, 24(3): 295-303.
135. Rodenburg R, Meijer AM, Dekovic M, Aldenkamp AP. Family factors and psychopathology in children with epilepsy: a literature review. Epilepsy Behav, 2005, 6(4): 488-503.
136. Goffman E. Stigma: notes on the management of spoiled identity. Englewood Cliffs, NJ: Prentice Hall, 1963.
137. Santosh D, Kumar TS, Sarma PS, et al. Women with onset of epilepsy prior to marriage: disclose or conceal? Epilepsia, 2007, 48(5): 1007-1010.
138. Lau KK, Ng PW, Chan CW, et al. Announcement of a new Chinese name for epilepsy. Epilepsia, 2011, 52(2): 420-421.
139. Hosseini N, Mokhtari S, Momeni E, et al. Effect of motivational interviewing on quality of life in patients with epilepsy. Epilepsy Behav, 2016, 55: 70-74.
140. McEwan MJ, Espie CA, Metcalfe J, et al. Quality of life and psychosocial development in adolescents with epilepsy: a qualitative investigation using focus group methods. Seizure, 2004, 13(1): 15-31.
141. Ellis N, Upton D, Thompson P. Epilepsy and the family: a review of current literature. Seizure, 2000, 9(1): 22-30.
142. Painter E, Rausch JR, Mod AC. Changes in daily activity patterns of caregivers of children with newly diagnosed epilepsy: a case-controlled design. Epilepsy Behav, 2014, 31: 1-6.
143. Mittan RJ. Psychosocial treatment programs in epilepsy: areview. Epilepsy Behav, 2009, 16(3): 371-380.
144. Glueckauf RL, Fritz SP, Ecklund-Johnson EP, et al. Video conferencing-based family counseling for rural teenagers with epilepsy: phase 1 findings. Rehabil Psychol, 2002, 47(1): 49-72.
145. Hufford BJ, Glueckauf RL, Webb PM. Home-based, interactive video conferencing for adolescents with epilepsy and their families. Rehabil Psychol, 1999, 44(2): 176-193.
146. Bernard RM, Abrami PC, Lou YP, et al. How does distance education compare with classroom instruction? A meta-analysis of the empirical literature. Rev Educ Res, 2004, 74(3): 379-439.
147. Lenhart A. Teen, social media and technology overview. Washington, DC: Pew Research Center, 2015.
148. Epilepsy Foundation. UPLIFT [cited 2017 Aug 6]. Availablefrom http://www.epilepsy.com/get-help/managing-your-epilepsy/self-management-programs/uplift.
149. MOSES [cited 2017 Aug 6]. Available from http://www.mosesschulung.de/moses/die-moses-trainer-trainerinnen/.
150. famoses [cited 2017 Aug 6]. Available from http://www.famoses.de/fileadmin/_migrated/content_uploads/FAMOSES-Flyer-Trainer-2011_09.pdf.

Previous Article
神经心理评估在癫痫术前评估中的应用
Next Article
心因性非癫痫性发作患者和癫痫患者心理治疗期间发作的频率及管理

Journal of Epilepsy

国际抗癫痫联盟心理工作组循证建议：成人和儿童癫痫患者的心理治疗

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content